kynurenic acid has been researched along with pentylenetetrazole in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (56.25) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Beal, MF; MacGarvey, U; Miller, J; Vécsei, L | 1 |
| Brodie, MJ; Connick, JH; Heywood, GC; Sills, GJ; Stone, TW; Thompson, GG | 1 |
| Oles, RJ; Singh, L; Tricklebank, MD | 1 |
| Peterson, SL | 1 |
| Kusá, R; Mares, P; Roztocilová, L; Velísek, L | 1 |
| Misawa, M; Suzuki, T; Tsuda, M | 1 |
| de Pádua Carobrez, A; De Souza, MM; Schenberg, LC | 1 |
| Lapin, IP | 1 |
| Easton, A; Gale, K; Walker, BR | 1 |
| Farkas, T; Nagy, D; Robotka, H; Rozsa, E; Sas, K; Toldi, J; Vecsei, L | 1 |
| Bidziński, A; Lehner, M; Maciejak, P; Płaźnik, A; Skórzewska, A; Sobolewska, A; Szyndler, J; Taracha, E; Turzyńska, D | 1 |
| Demeter, I; Fülöp, F; Gellért, L; Nagy, K; Toldi, J; Vécsei, L | 1 |
| Maciejak, P; Płaźnik, A; Sobolewska, A; Szyndler, J; Turzyńska, D | 1 |
| Dai, K; Hoshikawa, M; Niwa, O; Okada, M; Saito, H; Suzuki, N; Yamamura, S | 1 |
| Aiello, R; Camastra, C; Chimirri, S; Citraro, R; De Sarro, G; Donato, G; Mainardi, P; Perucca, E; Russo, E; Scicchitano, F | 1 |
16 other study(ies) available for kynurenic acid and pentylenetetrazole
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Kynurenine and probenecid inhibit pentylenetetrazol- and NMDLA-induced seizures and increase kynurenic acid concentrations in the brain.
Topics: Analysis of Variance; Animals; Brain; Cerebral Cortex; Corpus Striatum; Diazepam; Dose-Response Relationship, Drug; Kynurenic Acid; Kynurenine; Male; Mice; N-Methylaspartate; Pentylenetetrazole; Probenecid; Seizures | 1992 |
Nicotinylalanine increases cerebral kynurenic acid content and has anticonvulsant activity.
Topics: Alanine; Animals; Anticonvulsants; Brain Chemistry; Electroshock; In Vitro Techniques; Kidney; Kynurenic Acid; Liver; Male; Mice; Mice, Inbred Strains; Niacin; Pentylenetetrazole; Rats; Rats, Inbred Strains; Seizures; Tryptophan | 1992 |
Modulation of seizure susceptibility in the mouse by the strychnine-insensitive glycine recognition site of the NMDA receptor/ion channel complex.
Topics: Acoustic Stimulation; Animals; Aspartic Acid; Diazepam; Injections, Intraventricular; Ion Channels; Kynurenic Acid; Male; Mice; Mice, Inbred DBA; N-Methylaspartate; Pentylenetetrazole; Piperazines; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Seizures; Serine; Strychnine | 1990 |
Diazepam potentiation by glycine in pentylenetetrazol seizures is antagonized by 7-chlorokynurenic acid.
Topics: Animals; Diazepam; Drug Synergism; Glycine; Injections, Intraventricular; Kynurenic Acid; Male; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Seizures; Strychnine | 1994 |
Excitatory amino acid antagonists and pentylenetetrazol-induced seizures during ontogenesis: III. The action of kynurenic acid and glutamic acid diethylester.
Topics: Age Factors; Animals; Disease Models, Animal; Glutamic Acid; Kynurenic Acid; Male; Pentylenetetrazole; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Seizures | 1995 |
Recovery of decreased seizure threshold for pentylenetetrazole during diazepam withdrawal by NMDA receptor antagonists.
Topics: Animals; Anticonvulsants; Convulsants; Diazepam; Disease Models, Animal; Dizocilpine Maleate; Drug Interactions; Excitatory Amino Acid Antagonists; Infusions, Intravenous; Injections, Intraperitoneal; Injections, Subcutaneous; Kynurenic Acid; Male; Mice; Neuroprotective Agents; Pentylenetetrazole; Piperidines; Receptors, N-Methyl-D-Aspartate; Seizures; Substance Withdrawal Syndrome | 1997 |
NMDA-coupled periaqueductal gray glycine receptors modulate anxioselective drug effects on plus-maze performance.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Binding, Competitive; Central Nervous System Stimulants; Diazepam; Injections, Intraperitoneal; Kynurenic Acid; Male; Pentylenetetrazole; Periaqueductal Gray; Rats; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate | 1998 |
Antagonism of kynurenic acid to anxiogens in mice.
Topics: Animals; Anxiety; Brain; Caffeine; Diazepam; Excitatory Amino Acid Antagonists; Injections, Intraperitoneal; Kynurenic Acid; Male; Mice; Motor Activity; Pentylenetetrazole; Phenethylamines; Yohimbine | 1998 |
Regulation of limbic motor seizures by GABA and glutamate transmission in nucleus tractus solitarius.
Topics: Animals; Bicuculline; Electric Stimulation Therapy; Excitatory Amino Acid Antagonists; GABA Agonists; gamma-Aminobutyric Acid; Glutamates; Humans; Kynurenic Acid; Lidocaine; Limbic System; Male; Muscimol; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Seizures; Solitary Nucleus; Synaptic Transmission; Vagus Nerve | 1999 |
The pentylenetetrazole-induced activity in the hippocampus can be inhibited by the conversion of L-kynurenine to kynurenic acid: an in vitro study.
Topics: Animals; Convulsants; Dose-Response Relationship, Drug; Electrophysiology; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; GABA Antagonists; Hippocampus; Kynurenic Acid; Kynurenine; Nitroarginine; Pentylenetetrazole; Rats; Rats, Wistar | 2008 |
Time course of changes in the concentration of kynurenic acid in the brain of pentylenetetrazol-kindled rats.
Topics: Animals; Brain; Chromatography, High Pressure Liquid; Kindling, Neurologic; Kynurenic Acid; Male; Pentylenetetrazole; Rats; Rats, Wistar; Seizures | 2009 |
A novel kynurenic acid analog (SZR104) inhibits pentylenetetrazole-induced epileptiform seizures. An electrophysiological study : special issue related to kynurenine.
Topics: Action Potentials; Animals; Kynurenic Acid; Kynurenine; Male; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Seizures | 2012 |
Kynurenic acid: a new effector of valproate action?
Topics: Animals; Anticonvulsants; Hippocampus; Kindling, Neurologic; Kynurenic Acid; Male; Neurons; Pentylenetetrazole; Rats; Rats, Wistar; Seizures; Valproic Acid | 2011 |
ONO-2506 inhibits spike-wave discharges in a genetic animal model without affecting traditional convulsive tests via gliotransmission regulation.
Topics: Animals; Anticonvulsants; Astrocytes; Caprylates; Cells, Cultured; Convulsants; Disease Models, Animal; Electroshock; Epilepsy; gamma-Aminobutyric Acid; Glutamic Acid; Kynurenic Acid; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pentylenetetrazole; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Serine; Synaptic Transmission | 2013 |
Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis.
Topics: Animals; Convulsants; Epilepsy; Epilepsy, Absence; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Hippocampus; Kynurenic Acid; Lactalbumin; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Milk Proteins; N-Methylaspartate; Pentylenetetrazole; Pilocarpine; Rats; Tryptophan; Whey Proteins | 2012 |